Skip to search formSkip to main contentSkip to account menu

neuroblastoma screening

Known as: Screening for Neuroblastoma, early detection of neuroblastoma, neuroblastoma early detection 
The use of any device, marker, or other means for the purpose of detecting the presence of neuroblastoma, usually before there are symptoms.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Early Detection of Cancerscreening/prevention, cancer

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
PURPOSE Neuroblastoma screening in early infancy has detected predominantly "favorable" tumors. We postponed screening to an age… 
1999
1999
Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
PURPOSE Neuroblastoma screening during the first half-year of life is associated with a two- to three-fold overdiagnosis. Because… 
1998
1998
Neuroblastoma screening in the united states
Mass screening of infants for neuroblastoma began in Japan after studies suggested that survival rates could be improved by early… 
1998
1998
Neuroblastoma screening in the United States
We read with great interest the article by Yamashita et al., who suggest a direct correlation between the plasma thrombospondin… 
1997
1997
Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
BACKGROUND Encouraged by Japanese reports of the benefits of screening 6 month-old infants for neuroblastoma, a neuroblastoma… 
1996
1996
Effects of mass screening on age‐specific incidence of neuroblastoma
Using data from the Japan Children's Cancer Registry, we estimated the age‐specific incidence rates of neuroblastoma. Before the… 
1988
1988
Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine
SummaryWe screened urine for chemical individuality in over 1 million newborn infants, by various chromatographic (thin-layer… 
1987
1987
Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
We describe a simple and rapid method for measuring catecholamine metabolites in urine collected on filter paper. By this method… 
1987
1987
Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
Neuroblastoma is the most common fatal solid tumour of childhood. Studies in Japan suggest that screening urine at 6 months for… 
1986
1986
Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
In order to develop a mass screening method for the early detection of neuroblastoma, we measured urinary vanillylmandelic acid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)